Clearline Capital’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-784,449
| Closed | -$816K | – | 103 |
|
|
2024
Q3 | $816K | Hold |
784,449
| – | – | 0.03% | 122 |
|
|
2024
Q2 | $1.36M | Hold |
784,449
| – | – | 0.04% | 107 |
|
|
2024
Q1 | $1.87M | Buy |
+784,449
| New | +$1.87M | 0.09% | 88 |
|
|
2019
Q2 | – | Sell |
-24,723
| Closed | -$337K | – | 52 |
|
|
2019
Q1 | $337K | Buy |
24,723
+12,261
| +98% | +$167K | 0.18% | 37 |
|
|
2018
Q4 | $113K | Buy |
+12,462
| New | +$113K | 0.08% | 57 |
|